According to Science and Technology Daily, a research team from the University of Virginia in the United States has pioneered a new type of 3D printing material. This material is compatible with the human immune system and is expected to promote the rapid and safe development of various medical technologies such as artificial organ transplantation and drug delivery. This groundbreaking achievement was published in the latest issue of the journal Advanced Materials. Looking ahead, this material may be combined with other materials to manufacture 3D printed products with different chemical compositions, expanding various applications. For example, compared to existing solid polymer electrolytes, the new material exhibits higher conductivity and stretchability at room temperature, highlighting its potential as a high-performance solid electrolyte in advanced battery technology. The team stated that they will continue to explore its application prospects in solid-state battery technology. According to rough statistics from Securities Times·Data Treasure, over 40 companies in the A-share market are involved in the 3D printing industry. In the first three quarters of this year, there were 24 3D printing concept stocks with year-on-year net profit growth. Inno Laser, Chuangjiang New Materials, Aobo Zhongguang-UW, Bolite, and Yinhai Technology had the highest net profit growth rates. Among these 24 concept stocks with performance growth, as of the close on November 24, 6 had a rolling price-to-earnings ratio of less than 30 times, namely Lizhong Group, Yizumi Holdings, Yasha Co., Ltd., Yongli Co., Ltd., AIDITE TECH., and Changjiang Materials